Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-19

No worries @danishcookie

I welcome your half-glass empty to my half-glass full comments.
Patience will prevail.

Just BTW we will receive some more updates in between Sleep Apnoea and PSI-GAD,
PSI GAD is also split into circa 30 / 42 patients so I assume we will not have to wait for all 72 patients in the first instance?
I think the whole trial will take circa 12 months.

We can also expect
> results in vivo study on the protective effect of IHL-216A in traumatic brain injury and concussion (trial) nears conclusion
> US FDA pre-IND meeting for IHL-42X
> IHL-675 Phase 1, Clinical Trial Results
> New Psychedelic Trial anouncment
> New Left field Trial announcement

Also, these items give me a positive outlook ...

Good luck @danishcookie